Want to see SE:ORGC full AI Analyst Report?
ORGC Stock Chart & Stats
kr1.78
kr0.00(0.00%)
At close: 4:00 PM EST
kr1.78
kr0.00(0.00%)
Day’s Range― - ―
52-Week Rangekr0.20 - kr1.90
Previous CloseN/A
Volume11.05K
Average Volume (3M)229.12K
Market Cap
kr50.20M
Enterprise Valuekr130.45M
Total Cash (Recent Filing)kr480.00K
Total Debt (Recent Filing)kr78.56M
Price to Earnings (P/E)―
Beta0.84
Next Earnings
Nov 05, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.30
Shares Outstanding183,219,120
10 Day Avg. Volume143,305
30 Day Avg. Volume229,123
Financial Highlights & Ratios
PEG Ratio-0.05
Price to Book (P/B)11.75
Price to Sales (P/S)1.68
P/FCF Ratio-16.96
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.13
Revenue Forecast (FY)kr113.00M
Bulls Say, Bears Say
Bulls Say
Bio-based Chemistry PlatformOrganoClick addresses a structural shift toward replacing fossil-based and hazardous chemicals with more sustainable alternatives. Its proprietary bio-based chemistry and applications across wood, textiles and materials provide a platform for product adoption as customers pursue greener inputs.
Moderating Cash BurnAlthough cash generation remains negative, the reported reduction in free-cash outflow indicates some improvement in financial discipline or operating performance. If sustained, moderating burn could extend liquidity and reduce the pace at which the company must seek external funding.
Losses Improved From 2022Improvement from the exceptionally weak 2022 loss level shows that the company has demonstrated some ability to reduce losses over time. This is not yet profitability, but continued progress could support eventual operating leverage if revenue and margins stabilize.
Bears Say
Declining RevenueRevenue contraction weakens the foundation for scaling OrganoClick’s specialty chemistry business and suggests customer demand or product mix has not yet stabilized. Persistent declines would make it harder to absorb fixed costs, fund development and move toward sustainable profitability.
Deep Operating LossesDeep negative operating and net margins indicate that current sales do not cover the company’s cost base. Margin compression from earlier periods points to weaker pricing, mix or cost performance, limiting the likelihood that revenue growth alone will quickly translate into positive earnings.
High Leverage And Cash NeedsDebt of roughly 7.5 times equity, combined with negative operating and free cash flow, leaves limited financial flexibility. The company may need refinancing or new capital if losses and cash consumption persist, creating material dilution and refinancing risk over the medium term.
OrganoClick AB News
ORGC FAQ
What was OrganoClick AB’s price range in the past 12 months?
OrganoClick AB lowest stock price was kr0.20 and its highest was kr1.90 in the past 12 months.
What is OrganoClick AB’s market cap?
OrganoClick AB’s market cap is kr50.20M.
When is OrganoClick AB’s upcoming earnings report date?
OrganoClick AB’s upcoming earnings report date is Nov 05, 2026 which is in 29 days.
How were OrganoClick AB’s earnings last quarter?
OrganoClick AB released its earnings results on Aug 12, 2026. The company reported -kr0.037 earnings per share for the quarter.
Is OrganoClick AB overvalued?
According to Wall Street analysts OrganoClick AB’s price is currently Overvalued.
Does OrganoClick AB pay dividends?
OrganoClick AB does not currently pay dividends.
What is OrganoClick AB’s EPS estimate?
OrganoClick AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does OrganoClick AB have?
OrganoClick AB has 183,219,120 shares outstanding.
What happened to OrganoClick AB’s price movement after its last earnings report?
OrganoClick AB reported an EPS of -kr0.037 in its last earnings report. Following the earnings report the stock price went down -13.474%.
Which hedge fund is a major shareholder of OrganoClick AB?
Currently, no hedge funds are holding shares in SE:ORGC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
OrganoClick AB
OrganoClick AB (publ), a technology firm based in Täby, Sweden, was established in 2006. The company specializes in the development, production, and sale of innovative fiber-based materials and chemicals for applications spanning wood treatment, technical textiles, nonwovens, and biocomposites. Its diverse product portfolio includes OrganoWood, a wood preservation system that enhances wood's resistance to both rot and fire, primarily serving the construction industry and consumers. OrganoTex offers a biodegradable durable water repellent (DWR) technology for textiles, alongside related shoe and clothing care items. Additionally, OrganoComp is a biobased, plastic-free, and compostable composite designed to replace rigid plastics in 3D-molded products. For consumers, the BIOkleen brand provides a range of maintenance and cleaning solutions for wood, facades, roofs, terraces, and car care. Industrial clients benefit from OC-BioBinder, a biodegradable and plastic-free binder used in nonwovens and technical textiles as an alternative to conventional plastic binders, and OC-AquaSil Tex, a biodegradable water-repelling product that replaces PFAS chemicals in nonwovens, specialty papers, and technical textiles.
Technical Analysis
Hexpol AB
―
Nexam Chemical Holding AB
―
Svenska Aerogel Holding AB
―
Polygiene AB
―
Photocat A/S
―